Home BRILINTA Receives US FDA Approval For New Administration Option
 

Keywords :   


BRILINTA Receives US FDA Approval For New Administration Option

2015-04-01 08:02:52| drugdiscoveryonline Home Page

AstraZeneca recently announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow BRILINTA 90 mg tablets whole

Tags: option administration approval receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »